Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.594 SEK | -0.25% | -16.11% | -38.22% |
04-13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
04-12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Business Summary
Number of employees: 37
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Blood-based Biomarker Assays
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +65.43% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
96.3
%
| 2 | 95.0 % | 3 | 96.3 % | +67.68% |
European Union excluding Sweden
3.7
%
| 0 | 5.0 % | 0 | 3.7 % | +22.55% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anders Rylander
CEO | Chief Executive Officer | 54 | 09-12-31 |
Anders Morén
DFI | Director of Finance/CFO | 59 | 22-12-31 |
Hanna Ritzen
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-12-31 |
Tomas Andersson
COO | Chief Operating Officer | 64 | 19-12-31 |
Joakim Arwidson
LAW | General Counsel | 56 | 20-12-31 |
Helle Fisker
SAM | Sales & Marketing | 55 | 20-12-31 |
Corporate Officer/Principal | 58 | 19-11-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-03-19 | |
Annika Berg
BRD | Director/Board Member | 61 | 19-12-31 |
Maria Holmlund
BRD | Director/Board Member | 68 | 15-12-31 |
Director/Board Member | 73 | 13-12-31 | |
Anders Rylander
CEO | Chief Executive Officer | 54 | 09-12-31 |
Director/Board Member | 58 | 12-12-31 | |
Henrik Osvald
BRD | Director/Board Member | 65 | 18-12-31 |
Director/Board Member | 59 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,271,293 | 0 | 0 | 92.54 % |
Stock B | 1 | 77,784,267 | 77,784,267 ( 100.00 %) | 0 |
Company contact information
Biovica International AB
Dag Hammarskjölds väg 54B Uppsala Science Park
752 37, Uppsala
+46 1 84 44 48 30
http://www.biovica.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.22% | 12.29M | |
-20.55% | 10.81B | |
+47.97% | 3.36B | |
-32.75% | 2.22B | |
-14.15% | 2.16B | |
-26.06% | 1.55B | |
+19.85% | 1.04B | |
-2.62% | 746M | |
-31.67% | 425M | |
-43.88% | 405M |
- Stock Market
- Equities
- BIOVIC B Stock
- Company Biovica International AB